戻る Agenda
Healthcare 2030 – A Shared Ambition for Better Health for European Citizens
Session Chair(s)
Chris Walker, MSC
VP, Head of Regulatory Affairs (EU,LATAM,MiddleEast,Africa,CAN)
Amgen, United Kingdom
Healthcare systems in Europe are transforming through integrated approaches to deliver a personalised, sustainable healthcare system. Medicines remain an important part of an ecosystem that is evolving to embrace disruptive innovations: convergence between innovative drugs and / diagnostics / apps / algorithms; patients’ engagement in the social media era. This session will look at an emerging view of patients’ and society’s expectations for healthcare in 2030 and will focus on the role of stakeholders involved in the development of innovative medicines and those responsible for ensuring patient access.
Speaker(s)
Panelist
Tony Humphreys, MPHARM
European Medicines Agency, Netherlands
Head of the Regulatory Science and Innovation Task Force
Panelist
Nathalie Moll
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Director General
Panelist
Ceri Thompson
European Commission, Belgium
Panelist
Andrzej Rys, MD
European Commission, European Union, Belgium
Principal Scientific Advisor
Panelist
Sarunas Narbutas
President, Lithuanian Cancer Patient Coalition, POLA, Lithuania
Chairman of Youth Cancer Europe (YCE)
Panelist
Emer Cooke, MBA, MSC
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director